Anavex Life Sciences Corp.
AVXL
$2.76
-$0.10-3.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.94M | 12.47M | 12.80M | 13.82M | 12.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.27M | 38.37M | 44.33M | 50.76M | 53.50M |
| Operating Income | -17.27M | -38.37M | -44.33M | -50.76M | -53.50M |
| Income Before Tax | -13.00M | -34.07M | -39.93M | -46.38M | -48.17M |
| Income Tax Expenses | 18.00K | 18.00K | 18.00K | -- | -- |
| Earnings from Continuing Operations | -13.02 | -34.09 | -39.95 | -46.38 | -48.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.02M | -34.09M | -39.95M | -46.38M | -48.17M |
| EBIT | -17.27M | -38.37M | -44.33M | -50.76M | -53.50M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.15 | -0.39 | -0.46 | -0.54 | -0.57 |
| Normalized Basic EPS | -0.09 | -0.24 | -0.29 | -0.34 | -0.35 |
| EPS Diluted | -0.16 | -0.40 | -0.47 | -0.55 | -0.57 |
| Normalized Diluted EPS | -0.09 | -0.24 | -0.29 | -0.34 | -0.35 |
| Average Basic Shares Outstanding | 360.30M | 352.98M | 345.38M | 341.15M | 340.06M |
| Average Diluted Shares Outstanding | 360.50M | 352.98M | 345.38M | 341.15M | 340.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |